LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | PLX-4720 | 0.37 | uM | LJP5 | 3 | K04 | 72 | hr | 1476 | 4015 | 3694 | 1.0869 | 1.1447 |
| SK-BR-3 | QL-X-138 | 0.37 | uM | LJP6 | 1 | F22 | 72 | hr | 1476 | 1762 | 3694 | 0.4770 | 0.1287 |
| SK-BR-3 | QL-X-138 | 0.37 | uM | LJP6 | 2 | F22 | 72 | hr | 1476 | 1978 | 3694 | 0.5355 | 0.2261 |
| SK-BR-3 | QL-X-138 | 0.37 | uM | LJP6 | 3 | F22 | 72 | hr | 1476 | 1891 | 3694 | 0.5119 | 0.1868 |
| SK-BR-3 | QL-XII-47 | 0.37 | uM | LJP6 | 1 | O22 | 72 | hr | 1476 | 1444 | 3694 | 0.3909 | -0.0148 |
| SK-BR-3 | QL-XII-47 | 0.37 | uM | LJP6 | 2 | O22 | 72 | hr | 1476 | 1436 | 3694 | 0.3887 | -0.0184 |
| SK-BR-3 | QL-XII-47 | 0.37 | uM | LJP6 | 3 | O22 | 72 | hr | 1476 | 1331 | 3694 | 0.3603 | -0.0657 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP5 | 1 | K10 | 72 | hr | 1476 | 1859 | 3694 | 0.5032 | 0.1724 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP5 | 2 | K10 | 72 | hr | 1476 | 1581 | 3694 | 0.4280 | 0.0470 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP5 | 3 | K10 | 72 | hr | 1476 | 1610 | 3694 | 0.4358 | 0.0601 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP6 | 1 | K10 | 72 | hr | 1476 | 1631 | 3694 | 0.4415 | 0.0696 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP6 | 2 | K10 | 72 | hr | 1476 | 1654 | 3694 | 0.4478 | 0.0800 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP6 | 3 | K10 | 72 | hr | 1476 | 1649 | 3694 | 0.4464 | 0.0777 |
| SK-BR-3 | Seliciclib | 0.37 | uM | LJP5 | 1 | J04 | 72 | hr | 1476 | 4035 | 3694 | 1.0923 | 1.1538 |
| SK-BR-3 | Seliciclib | 0.37 | uM | LJP5 | 2 | J04 | 72 | hr | 1476 | 3824 | 3694 | 1.0352 | 1.0586 |
| SK-BR-3 | Seliciclib | 0.37 | uM | LJP5 | 3 | J04 | 72 | hr | 1476 | 3994 | 3694 | 1.0812 | 1.1353 |
| SK-BR-3 | Ruxolitinib | 0.37 | uM | LJP5 | 1 | O16 | 72 | hr | 1476 | 3041 | 3694 | 0.8232 | 0.7055 |
| SK-BR-3 | Ruxolitinib | 0.37 | uM | LJP5 | 2 | O16 | 72 | hr | 1476 | 3415 | 3694 | 0.9245 | 0.8742 |
| SK-BR-3 | Ruxolitinib | 0.37 | uM | LJP5 | 3 | O16 | 72 | hr | 1476 | 3631 | 3694 | 0.9829 | 0.9716 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 1476 | 4585 | 3694 | 1.2412 | 1.4018 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 1476 | 4241 | 3694 | 1.1481 | 1.2467 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 3 | G10 | 72 | hr | 1476 | 4027 | 3694 | 1.0901 | 1.1502 |
| SK-BR-3 | Saracatinib | 0.37 | uM | LJP6 | 1 | D10 | 72 | hr | 1476 | 3895 | 3694 | 1.0544 | 1.0906 |
| SK-BR-3 | Saracatinib | 0.37 | uM | LJP6 | 2 | D10 | 72 | hr | 1476 | 3884 | 3694 | 1.0514 | 1.0857 |
| SK-BR-3 | Saracatinib | 0.37 | uM | LJP6 | 3 | D10 | 72 | hr | 1476 | 3666 | 3694 | 0.9924 | 0.9874 |